期刊文献+

61例肺间质纤维化患者临床证候调查分析 被引量:9

Investigation and analysis on TCM syndrome manifestations in 61 patients with pulmonary interstitial fibrosis
原文传递
导出
摘要 目的探讨肺间质纤维化的临床证候信息,并比较肺纤维化虚证证候与肺CT评分、SF-36量表各维度得分的关系。方法对所收集的61例患者应用聚类分析的统计方法,初步总结肺间质纤维化患者的临床证候信息,并应用秩和检验方法比较肺纤维化各虚证证候与肺CT评分、SF-36量表各维度得分的关系。结果聚类分析与经验辨证结果均为肺肾气虚、瘀血内阻是肺纤维化的临床常见证候,肺脾肾虚组、肺肾虚组肺CT评分相对较高,SF-36量表维度中躯体功能得分较低。结论肺肾气虚、瘀血内阻为肺纤维化的临床常见证候,涉及肾虚的证候肺纤维化病变相对较重。 Objective To discuss the clinical information of pulmonary interstitial fibrosis (PIF), and compare the relationship between the TCM syndrome manifestations of PIF deficient syndrome and lung CT scores and dimensional scores of SF-36 scale. Methods Clustering method was used in 61 cases of PIF and their chnical information were summed up. The TCM syndrome manifestations of PIF deficient syndrome were compared with lung CT scores and dimensional scores of SF-36 scale by applying rank test. Results The results of both clustering analysis and experiences showed that lung-kidney deficiency and internal blood stasis were the common syndrome manifestations of PIF in clinic, lung CT scores were higher in lung-spleen-kidney deficiency group and lung-kidney deficiency group, and the scores of somatic function were lower in dimensionality of SF- 36 scale. Conclusion The common syndrome manifestations of PIF include lung-kidney deficiency and internal blood stasis. The pathological changes of PIF involving kidney deficiency are more serious.
出处 《北京中医药大学学报(中医临床版)》 2010年第4期1-4,共4页 Journal of Beijing University of Traditional Chinese Medicine
基金 首都医学科技发展基金资助项目(No.2005-sf-Ⅱ-014)
关键词 肺纤维化 证候调查 聚类分析 秩和检验 pulmonary interstitial fibrosis investigation on syndrome manifestations clustering analysis rank test
  • 相关文献

参考文献8

二级参考文献47

  • 1许祖德,张月娥,陈忠年,徐元鼎,张秀荣,王新禾.傅莱霉素诱发大鼠肺纤维化时肺内间质细胞的变化[J].上海医科大学学报,1995,22(2):93-96. 被引量:14
  • 2师锁柱,陈香美.细胞间粘附分子-1在非IgA系膜增殖性肾小球肾炎病变中表达的定量分析[J].临床与实验病理学杂志,1996,12(1):31-33. 被引量:2
  • 3国家技术监督局.中医临床诊疗术语-证候部分[M].北京:中国标准出版社,1998.13.
  • 4American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society(ATS) and the European Respiratory Society(ERS)[J]. Am J Respir Crit Care Med, 2000, 161(2pt): 646-664.
  • 5Szapiel SV, EIson NA, Fulmer JD,et al. Bleomycin_induced intersti-tial pulmomary disease in the nude, authymic mouse [J]. Amer Rev Resp Dis, 1979,120:893-896.
  • 6COKERRR,LAURENT GJ.Anticy tokine approaches inpulmonary fibrosis : bring factor into focus[J].Thorax,1997,52(5):294-296.
  • 7ROBERT J,MASONT, MARVINI, et al. Pharmacological the rapy for idiopathic pulmonary fibrosis [J].Am j Respri Crit Care Med, 1999,160(4):1771-1777.
  • 8Sato N,Suzuki Y,Nishio K,et al.Roles of ICAM-1 for abnormal leukocyte recruitment in the microcirculation of bleomycin-induced fibrotic lung injury [J].Am J Respir Crit Care Med,2000,161 (5):1681 - 1688.
  • 9Ware JE Jr, Snow KK, Kosinski M, et al.SF-36 health survey manual and interpretation guide.Boston: New England Medical Center the Health Institute,1993.1-12.
  • 10Perneger TV, Leplege A, Etter JF,et al.Validation of a French-language version of the MOS 36-Item Short Form Health Survey(SF-36) in young healthy adults.J Clin Epidemiol, 1995,48:1051-1060.

共引文献2803

同被引文献122

引证文献9

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部